RE: Good idea20 Nov 2020 17:04
The mask has been designed by Nottingham Trent University scientist and nanotechnology expert, Dr Gareth Cave, and Pharm2Farm’s CEO Dr Karen Davies and is now being commercialised by Pharm2Farm in their new state of the art facilities at Nottingham’s BioCity.
Pharm2Farm has purchased an automated face mask production line, which is on track to be delivered this month (November 2020). The production line, which is manufactured in Europe, has the capacity to produce up to five million anti-viral face masks per month.
Tests showed that the masks, which are Type IIR – meaning they offer the highest level of protection and have a filtration efficiency of 99.98%– were highly effective, at killing more than 90% of the influenza and coronavirus over seven hours, and has been certified to ISO 18184 standards.
The masks include a fluid-repellent layer on the outside – to reduce inhalation of droplets of saliva and mucus that carry COVID-19, the antiviral nanotech layer between two anti-viral filter layers, and a soft hypoallergenic breathable innermost layer.